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The Use of Corticosteroids in Occular 
Disease of Small Animals 
Doug Hildebrand* 
Introduction 
Corticosteroids are of great value in the 
treatment of inflammatory diseases of the 
eye. Acute inflammations which are treat-
ed early respond rapidly, and relapse is 
uncommon after therapy is discontinued. 
Chronic conditions respond more slowly 
and relapses aTe much more likely to oc-
cur. Used correctly, cOJ.1ticosteroids can 
improve the chances of successful treat-
ment of many ocular conditions in small 
animals. 
Indications 
Corticosteroids are used as a part of the 
treatment of acute and catarrhal conjuc-
tivitis. Generally, an ointment form con-
taining antibiotics and corticosteroids is 
used several times per day. Chemosis and 
injection of the conjuctiva are markedly 
reduced. Corticosteroids are also used in 
purulent conjuctivitis. In this disease, cor-
ticosteroids are used topically in ointment 
form with an antibiotic or antibiotic com-
bination. However, there are certain pre-
cautions to be taken here. First, the fluor-
escein stain of the cornea should be done 
to determine if corneal ulceration is pre-
sent. Corticosteroids topically are contra-
indicated in the presence of corneal ulcers 
since corticosteroids inhibit epithelization 
.* Mr. Hildebrand is a junior in the College of Vet-
ennary Medicine at Iowa State University. 
Issue, No.2, 1969 
and thus delay wound healing. Also in 
cats, a conjuctival scrape is indicated be-
fore instituting local corticosteriod ther-
apy. The conjuctival scrape is stained 
with Geimsa stain and examined micro-
scopically for red intracellular inclusion 
bodies. These inclusion' bodies indicate a 
viral etiology, and corticosteroids would 
reduce antibody formation in response to 
the virus, thus making the condition worse. 
In follicular conjuctivitis of the third 
eyelid, corticosteroids are used topically in 
ointment form to reduce the swelling, 
edema, and congestion of the third eyelid 
as well as reduce the catarrhal exudate 
from the lymphatic tissue of the third eye-
lid. 
Corticosteroids ate indicated in some 
keratopathies. Generally speaking, the re-
sult of the fluorescein dye test is the decid-
ing factor in the use of topical corticoster-
oids. If erosion or ulceration exists, topical 
corticosteroids are contraindicated gener-
ally. The only exception is after corneal 
trauma or an old corneal ulcer when ster-
oids are used to reduce neovascularization, 
scarring and pigmentation. 
In ulcerative keratitis with panuveitis, 
corticosteroids are not used topically as a 
rule, but they may be used systemically. 
The rationale for their systemic use is ,that 
with this method of administration, the 
concentration of corticosteroids is high 
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only in the posterior segment of the eye 
and that sufficient quantities of corticoster-
oids to inhibit epithelization of the ulcer 
are not present in the cornea. However, 
the quantities at the perilimbal plexus are 
thought to be sufficient to bring the per-
meability of these vessels back towards 
normal, thus allowing the edematous fluid 
in the corneal stroma to be removed and 
allows the cornea to become transparent 
again, reducing the time required for heal-
ing. 
Another indication for corticosteroids is 
idiopathic pannus in the German Shep-
herd. 'Steroids are used to cause regression 
of neovascularization and granulation tis-
sue growth. Here steroids are applied top-
ically and also subcapsularly. Subcapsular 
administration is accomplished by injec-
tion beneath Tenon's Capsule, providing 
a slow release of corticosteroid and a 
longer therapeutic effect. It should be re-
membered that steroids only arrest this 
disease, they do not cure it. 
One of the most important uses of corti-
costeroids is in the treatment of uveitis. 
Here early steroid therapy is important so 
that there is minimal damage to the cho-
roid as a result of the inflammatory reac-
tion. Prednisolone solutions are often used 
intramuscularly so that high concentra-
tions of steroids are attained in the poster-
ior segment of the eye. Also, subcapsular 
injections of prednisolone may be used 
here because of the accompanying inter-
stitial keratitis which is seen frequently 
with uveitis. Before using steroids sub-
capsularly, however, a fluorescein dye test 
should be used to make sure there are no 
corneal ulcers. 
Contraindications 
Corticosteroids can complicate any ac-
tive infection if given systemically. Usu-
ally, this can be avoided by the use of 
effective antimicrobial compounds in con-
junction with steroids. However, if the 
infection is severe or the antibotic is in-
effective, the condition can be worsened 
or activated. 
In diabetes mellitus, systemic steroids 
are contraindicated due to their glucocor-
ticoid actions, one of which is the hyper-
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glycemic effect. Steroids also complicate 
hypertension as well as electrolyte im-
balances. Also, it should be remembered 
that ·they delay wound healing. 
The fact that corticosteroids inhibit epi-
t:helization of the cornea is well known 
and well accepted. This makes the diag-
nosis of corneal ulcers very important 
since locally applied steroids can seriously 
prolong the healing of a corneal ulcer or 
laceration. Local eye infections when 
treated with corticosteroids may progres-
sively grow worse in the presence of local 
steroid therapy if specific, effective anti-
biotics are not used along with the steroid. 
One very definite contraindication for 
corticosteroids is in the uveitis and intersti-
tial keratitis following infectious canine 
hepatitis. Generally speaking, any viral 
disease of the eye contraindicates the use 
of steroids since the body's defense mecha-
nisms are inhibited by this drug. 
Post vaccinal keratitis is another con-
traindication. The mechanism seems to 
be a delayed hypersensitive reaction with 
regional vascular thrombosis and endothe-
lial damage. Corticorsteroids, it is believed, 
would inhibit the natural vascular re-
sponse of the body resulting in permanent 
damage to the eye. 
Routes of Administration and Dosage 
Topical therapy is effective in anterior 
segment disease including diseases of the 
lids, conjuctiva, cornea, iris, and ciliary 
body. Ease of application, relatively low 
cost, and absence of systemic complica-
tions strongly favor local routes whenever 
they are effective. Unusually stubborn an-
terior segment diseases may require sup-
plementary systemic, subcapsular, or sub" 
conjuctival medication. 
Posterior segment diseases such as cho-
rioretinitis, panuveitis, optic neuritis, and 
posterior scleritis, are not appreciably af-
fected by topical steroids and require sys-
temic therapy. Oral administration of ster-
oids is one method of attaining systemic 
therapeutic levels. Orally, peak concen-
trations are reached in one hour and are 
about at normal levels in six hours so 
therapy will be required three or four times 
each day. 
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Dosage will vary with the severity of 
the disease. The degree of response is 
directly related to dosage, and therefore, 
the dose of steroid should 'be proportional 
to the severity of the individual disease. 
For topical use, usually increased fre-
quency of application is equally or more 
effective than a stronger concentration. 
Discussion 
Many synthetic corticosteroids are avail-
able for use in veterinary medicine, as 
well as cortisone and hydrocovtisone. Many 
of the newer synthetics have tremendous 
anti-inflammatory effects with minimal 
effects on electrolyte levels and carbohy-
drate metabolism. All steroid derivatives 
have some undesirable side effects, but 
the proportionate risk of these side effects 
is less in the newer steroids. The thera-
peutic respon,se of locally applied cortico-
steroids seems to require the same amount 
of concentration regardless of which ster-
oid is used. Hydrocortisone is biologically 
more active and potent than cortisone and 
has been demonstrated to be more effec-
tive tha:n cortisone against certain super-
ficial eye conditions. For this reason, 
mainly hydrocortisone is used in opthalmic 
ointments and solutions. 
Corticosteroids decrease cellular and 
fibrinous exudation and tissue infiltration, 
inhibit fibroplastic and collagen-forming 
activity, inhibit neovascularization, and re-
store toward normal the excessive perme-
ability of inflamed capillaries. The mech-
anisms by which these effects are produced 
are not known but are thought to be in-
direct, such as suppression of the sub-
stances which induce tissue activity in re-
sponse to inflammation or trauma. The 
anti-inflammatory effects of steroids are 
nonspecific, occurring whether the etiology 
is allergiC, traumatic, or infectious. 
The anti-inflammatory effects of corti-
costeroids have been most useful in ocula:r 
rlisease because the delicate and trans-
parent ocular structures are particularly 
susceptible to functional damage by in-
flammation and scarring. 
In general, therapeutic responses are 
obtained in inflammations such as uveitis 
and scleritis and in all forms of ocular 
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allergy. Steroids reduce resistance to many 
types of such infections except simultane-
ously with an effective antibiotic or other 
antibacterial medications. Degenerative 
diseases are completely refractory to ster-
oids. 
Corticosteroids will reduce toward nor-
mal the increased capillary permeability 
characteristic of inflammation, and the re-
sulting edema. This is of therapeutic effect 
by stopping abnormal cellular and protein 
leakage into the aqueous humor. The tis-
sue infiltration and surface exudation of 
nentrophils, lymphocytes and mononuclear 
cells are markedly inhibited by corticoster-
oids. • 
Formation of collagen and fibroblastic 
activity are definitely inhibited by cortico-
steroids. This is desirable in the preven-
tion of corneal scarring but is disadvan-
tageous during the healing of surgical 
wounds. 
Despite the general agreement that ster-
oids tend to inhibit wound healing, clinical 
experience indicates that ocular surgery 
can be performed with impunity during 
sterioid therapy in moderate doses. How-
ever, unless required by'severe uveitis or 
some similar medical indication, steroid 
therapy is best postponed until several 
days postoperatively, by which time fibro-
blastic activity is already well advanced. 
One of the most useful therapeutic ac-
tions of steroids is in inhibition of neovas-
cularization. Cortisone has a nonspecific 
vasoconstrictor effect which may contrib-
ute to this inhibition of neovascularization, 
and which may induce regression of exist-
ing vessels. 
A relatively minor disadvantage of cor-
ticosteroids is the inhibition of epithelial 
and endothelial regeneration. 
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